13F HOLDINGS REPORT
TCG Crossover Management, LLC
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001214659-23-011170
Total Value
$609.8M
Positions
22
Other Managers
0
Confidential Omitted
No
Holdings (22)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | IVERIC BIO INC | 46583P102 | 2,448,829 | $96.3M | 15.80% |
| 2 | GERON CORP | GERN | 23,589,779 | $75.7M | 12.42% |
| 3 | COGENT BIOSCIENCES INC | COGT | 5,631,042 | $66.7M | 10.93% |
| 4 | VECTIVBIO HOLDING AG | H9060V101 | 3,113,600 | $52.9M | 8.68% |
| 5 | AEROVATE THERAPEUTICS INC | 008064107 | 2,201,274 | $37.8M | 6.19% |
| 6 | ICOSAVAC, INC | 45114M109 | 3,703,704 | $36.8M | 6.03% |
| 7 | MADRIGAL PHARMACEUTICALS INC | MDGL | 149,917 | $34.6M | 5.68% |
| 8 | TYRA BIOSCIENCES INC | TYRA | 1,989,103 | $33.9M | 5.56% |
| 9 | KALVISTA PHARMACEUTICALS, INC | KALV | 3,395,495 | $30.6M | 5.01% |
| 10 | VENTYX BIOSCIENCES, INC | 92332V107 | 815,724 | $26.8M | 4.39% |
| 11 | DYNE THERAPEUTICS, INC | DYN | 1,650,150 | $18.6M | 3.04% |
| 12 | KURA ONCOLOGY INC | KURA | 1,423,642 | $15.1M | 2.47% |
| 13 | STRUCTURE THERAPEUTICS INC | GPCR | 350,000 | $14.5M | 2.39% |
| 14 | IMMUNOVANT, INC | IMVT | 654,853 | $12.4M | 2.04% |
| 15 | SILENCE THERAPEUTICS PLC | SLNCF | 2,104,875 | $11.6M | 1.90% |
| 16 | AN2 Therapeutics, Inc. | ANTX | 1,289,320 | $11.0M | 1.80% |
| 17 | ENTRADA THERAPEUTICS INC | TRDA | 584,955 | $8.9M | 1.45% |
| 18 | MERUS BV | N5749R100 | 300,000 | $7.9M | 1.30% |
| 19 | CABALETTA BIO, INC | CABA | 486,795 | $6.3M | 1.03% |
| 20 | ACLARIS THERAPEUTICS INC | ACRS | 529,839 | $5.5M | 0.90% |
| 21 | C4 THERAPEUTICS, INC. | CCCC | 1,276,574 | $3.5M | 0.58% |
| 22 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 253,069 | $2.6M | 0.43% |